Today, PatientIQ announced $30 million in Series C funding, led by Hughes & Company, with Travis Hughes joining our Board of Directors. It's a milestone we're proud of, and one that reflects a broader shift happening across the healthcare industry right now.
For years, the conversation around patient-reported outcomes followed a familiar pattern. Clinicians understood the value, researchers wanted the data, and health systems knew measurement mattered. And yet, systematic outcomes collection remained the exception rather than the rule. That's changing, and faster than most of the industry expected.
CMS is expanding patient-reported outcome requirements across surgical and procedural specialties. Payers are increasingly tying reimbursement to demonstrated clinical results rather than volume of services delivered. Medical device and life sciences companies face growing regulatory and commercial pressure to generate real-world evidence, data that can only come from patients being systematically measured in clinical settings, at scale. The industry is being pushed, from multiple directions at once, toward a simple but consequential requirement: prove that care works — and most organizations don't yet have the infrastructure to do it.
Outcomes data have always existed in healthcare. Patients report how they feel, surgeons observe results, and registries capture snapshots of performance over time. But when that data lives outside clinical workflows, it doesn't get collected consistently. When it can't be benchmarked across organizations, it can't drive meaningful improvement. And when insights never reach the point of care, they can't change how patients are treated.
This is the gap PatientIQ was built to close. Not by adding another data collection tool to an already burdened clinical environment, but by building outcomes measurement directly into the workflows providers already use, inside the EHR, automated, and connected across organizations. The result is outcomes intelligence that actually works in practice: high collection rates, consistent data quality, and benchmarks that mean something because they're drawn from a network of hundreds of organizations measuring the same patients in the same way.
As Matthew Gitelis, CEO of PatientIQ, put it: "The reason outcomes data has been so hard to act on in healthcare isn't a lack of will. It's a lack of infrastructure. Building that infrastructure, specialty by specialty, workflow by workflow, is what PatientIQ has been doing for a decade. This investment is validation that the approach is working, and the fuel to take it much further."
Since our Series B in 2022, PatientIQ has grown from 200 healthcare organizations to more than 870, expanded our network patient population to over 17 million, and surpassed 70 million patient outcomes collected. We integrate with more than 50 EHR systems, including Epic, Oracle Cerner, and Athenahealth, and serve organizations across more than 20 medical specialties. We power national registries for AAOS, AANS, and the Society for Thoracic Surgeons. That growth isn't incidental. It reflects a market that is ready for this infrastructure and increasingly understands why having it matters.
This investment accelerates growth in three areas that reflect where the industry is heading. First, we're going deeper into the specialties and health systems we already serve. The benchmarks that make outcomes data meaningful get stronger as more organizations contribute to them, which means network growth benefits every organization already on the platform. Second, we're expanding our real-world evidence platform for medical device and life sciences companies. As regulatory and commercial pressure for outcomes evidence intensifies, PatientIQ is positioned to provide industry partners with faster access to high-quality, EHR-integrated outcomes data generated within clinical workflows rather than extracted from them after the fact. Third, we're building a direct-to-patient experience through our growing marketplace, connecting patients to the products and services that support their care journey and creating a new layer of engagement between outcomes data and the people it ultimately serves.
Travis Hughes, Founder and Managing Partner of Hughes & Company, shared why the firm led the round: "We spent a year studying the patient-reported outcomes space. What we found in PatientIQ is something rare — a company that helped create and define an entirely new category that has a meaningful impact on quality of care. We are excited to be part of PatientIQ's next chapter of growth."
The shift toward outcomes-based care is not a trend. It's a structural change in how healthcare is measured, reimbursed, and evaluated. The organizations that build the infrastructure to participate in that shift now will be better positioned for what comes next, whether that's CMS reporting requirements, payer contracts, registry participation, or real-world evidence generation for device submissions. PatientIQ exists to make that infrastructure accessible, not just to the largest health systems with dedicated data teams, but to any organization that delivers care and wants to understand whether it's working.
Outcomes data have always existed in healthcare. We're building the infrastructure to make it matter.